Acacia (ACHC) was downgraded to neutral from overweight at Cantor Fitzgerald. $45 price target. Earnings estimates were also cut, as acquisitions are being pushed out, Cantor said.
Emerson (EMR) was upgraded to neutral at Goldman Sachs. $60 price target. The company is seeing signs of better industrial growth, Goldman said.
Ford (F) was upgraded to outperform at RBC Capital. $14 price target. The valuation is more attractive, as the stock has lagged GM by 21% since last September, RBC said.
Intel (INTC) was upgraded to equal-weight at Morgan Stanley. $38 price target. Management should be able to achieve more realistic guidance, Morgan said.
Neurocrine Bio (NBIX) was upgraded to outperform at Oppenheimer. $55 price target. The valuation is more attractive, as the stock is down 22% over the past two months, Oppenheimer said.
Primoris (PRIM) was upgraded to buy from hold at Canaccord Genuity. $28 price target. The company has better visibility for growth and margins, Canaccord said.
Praxair (PX) was upgraded to overweight from neutral at JPMorgan. $125 price target. The company stands to benefit from increased U.S. industrial activity, JPMorgan said.
Timken (TKR) was upgraded to buy at Goldman Sachs. $55 price target. Organic growth will likely inflect higher in the second quarter, Goldman said.
Weatherford (WFT) was downgraded to hold from buy at Jefferies. $6 price target. Expect weaker international results in the coming quarters, Jefferies said.
Whirlpool (WHR) was downgraded to neutral from buy at Goldman Sachs. $187 price target. Margin compression risks are mounting, Goldman said.
Wynn Resorts (WYNN) was upgraded to neutral from reduce at Nomura. $99 price target. New property managers are helping to drive market share gains, Nomura said.